Insulin pumps and CGM can be combined as part of an automated insulin delivery (AID) system, where data from each device flows through an algorithm to determine insulin-delivery rates and automatically adjust them to keep glucose values in a specific range, requiring less work from people with diabetes and also improving quality of life outcomes [1]. The gene discussed is INS; the disease is diabetes mellitus.